Efficacy and Safety of the Doxazosin Gastrointestinal Therapeutic System for the Treatment of Benign Prostate Hyperplasia
Author:
Publisher
Wiley
Subject
General Medicine
Reference19 articles.
1. Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Doubleblind trial of efficacy and tolerability;Gratzke;Fortschr Med Orig,2000
2. A combined analysis of double-blind trials of the efficacy and to-lerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia;Kirby;BJU Int,2001
3. Clinical pharmaco-kinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation;Chung;Br J Clin Pharmacol,1999
4. Controlled-release doxazosin in the treatment of benign prostatic hyper-plasia;Hernandez;Prostate Cancer Prostatic Dis,2005
5. Doxazosin gastrointestinal therapeutic system: a review of its use in benign prostatic hyperplasia;Goldsmith;Drugs,2005
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and tolerability of doxazosin gastro-intestinal therapeutic system versus tamsulosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia;Medicine;2021-08-20
2. Chitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate: in vitro, and in vivo evaluation;Drug Development and Industrial Pharmacy;2019-05-03
3. Identification of 3,4-dihydro-2 H -thiochromene 1,1-dioxide derivatives with a phenoxyethylamine group as highly potent and selective α 1D adrenoceptor antagonists;European Journal of Medicinal Chemistry;2017-10
4. Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective α1A-Adrenoceptor Antagonists;Journal of Medicinal Chemistry;2016-04-13
5. Antihypertensive drugs;A worldwide yearly survey of new data in adverse drug reactions and interactions;2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3